Normalization was carried out to account for technical variation, and keratins identified in blank Schirmer strip controls were removed, as previously published 30
In addition, we have demonstrated that oxidative stress is a major factor influencing antibiotic persistence in S
Interaction terms for follow-up duration, AHM initiation status, sex, age, and mean BP were included in the regression models
Safety and Efficacy Considerations While this therapy shows remarkable promise, its important to note: Treatment should be administered by qualified healthcare professionals Individual response rates may vary Regular monitoring ensures optimal outcomes Integration with other therapeutic approaches may enhance results Glutathione therapy represents a significant advancement in regenerative medicine, offering hope for patients with various chronic conditions
Baseline Assessment Before Starting ALA Before adding ALA at any dose to a rosuvastatin regimen, obtain or review: Fasting plasma glucose and HbA1c (to characterize baseline glycemic status) TSH (to rule out pre-existing hypothyroidism that could worsen) Creatine kinase (to document a baseline in case myalgia develops and thyroid effects are later implicated) Ongoing Monitoring by Dose At ALA doses of 300 mg/day or below in normoglycemic patients, no additional monitoring beyond routine statin follow-up is required